Search clinical trials for: BEZ235,
Total 25 results
-
PfizerCompletedSolid Tumor | Unspecified Adult Solid Tumor, Protocol SpecificUnited States, Australia, Canada, France, Spain
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Cliniques universitaires Saint-Luc- Université...NovartisTerminatedCarcinoma Transitional CellBelgium, Luxembourg
-
Memorial Sloan Kettering Cancer CenterNovartisTerminated
-
Novartis PharmaceuticalsWithdrawnMalignant PEComa (Perivascular Epithelioid Cell Tumors)Spain
-
Novartis PharmaceuticalsWithdrawn
-
Restorbio Inc.Active, not recruitingRespiratory Tract InfectionsUnited States
-
Novartis PharmaceuticalsCompletedBreast Cancer | Advanced Solid Tumors | Cowden SyndromeNetherlands, Spain, Germany, United Kingdom, United States
-
Novartis PharmaceuticalsWithdrawnEndometrial CancerUnited States, Russian Federation, Germany, Singapore, Italy, Spain, France, Brazil, Canada, Japan, Poland, Turkey
-
Novartis PharmaceuticalsCompletedPancreatic Neuroendocrine Tumors (pNET)France, Spain, Belgium, Germany, Italy, United Kingdom, Austria, Netherlands, United States
-
Novartis PharmaceuticalsCompleted
-
Restorbio Inc.WithdrawnClinically Symptomatic Respiratory Illness
-
Medical Research CouncilMerck Sharp & Dohme LLC; Aarhus University Hospital; NCRI Clinical Studies Groups and other collaboratorsUnknownGlioblastomaUnited States, Italy, Belgium, Germany, Poland, Russian Federation, Spain, Switzerland, Ukraine, United Kingdom
-
Goethe UniversityCompletedA Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute LeukemiaAcute Lymphoblastic Leukemia | Leukemia, Myelocytic, Acute | Chronic Myelogenous Leukemia With Crisis of Blast CellsGermany
-
Novartis PharmaceuticalsTerminatedPancreatic Neuroendocrine Tumors (pNET)United Kingdom, Spain, Netherlands, Italy, Russian Federation, France, Switzerland, United States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
SCRI Development Innovations, LLCNovartisCompletedMalignant Solid TumourUnited States
-
Restorbio Inc.National Institute on Aging (NIA)Active, not recruitingCovid19United States
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast CancerSpain, Belgium, Italy, France, United States, New Zealand, United Kingdom
-
Restorbio Inc.Terminated
-
University of CincinnatiNovartisTerminated
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer (MBC) | Inoperable Locally Advanced Breast CancerFrance, Spain
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain